INTANGIBLE ASSETS, NET (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets
Accumulated Amortization	$ (384,712)	$ (272,141)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	4,477,391	3,371,888
Net Amount	4,092,679	3,099,747
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,855,279	1,721,305
Net Amount	1,855,279	1,721,305
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	264,289	233,275
Net Amount	264,289	233,275
Domestic Utilty Patent - Opera Software [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(10,484)	(8,487)
Net Amount	$ 21,467	$ 23,464
Weighted average remaining amortization period	10 years 9 months	11 years 9 months
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 2,234,129	$ 1,293,614
Accumulated Amortization	(282,485)	(171,911)
Net Amount	$ 1,951,644	$ 1,121,703
Weighted average remaining amortization period	14 years	15 years
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	$ (91,743)	$ (91,743)